Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis Yang HPharm Res 2010[Sep]; 27 (9): 1759-71Central nervous system (CNS) diseases represent the largest and fastest-growing area of unmet medical need. Nanotechnology plays a unique instrumental role in the revolutionary development of brain-specific drug delivery, imaging, and diagnosis. With the aid of nanoparticles of high specificity and multifunctionality, such as dendrimers and quantum dots, therapeutics, imaging agents, and diagnostic molecules can be delivered to the brain across the blood-brain barrier (BBB), enabling considerable progress in the understanding, diagnosis, and treatment of CNS diseases. Nanoparticles used in the CNS for drug delivery, imaging, and diagnosis are reviewed, as well as their administration routes, toxicity, and routes to cross the BBB. Future directions and major challenges are outlined.|*Central Nervous System Diseases/diagnosis/drug therapy[MESH]|*Magnetic Resonance Imaging[MESH]|*Nanoparticles/chemistry/toxicity[MESH]|Animals[MESH]|Blood-Aqueous Barrier/*metabolism[MESH]|Dendrimers/chemistry/pharmacokinetics/toxicity[MESH]|Drug Carriers/*chemistry/pharmacokinetics/toxicity[MESH]|Endothelial Cells/drug effects/metabolism[MESH]|Ferric Compounds/chemistry/pharmacokinetics/toxicity[MESH]|Humans[MESH]|Liposomes[MESH]|Pharmaceutical Preparations/administration & dosage[MESH]|Quantum Dots[MESH]|Transcytosis/drug effects[MESH] |